A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

A large majority of older Americans feel that health insurance—including Medicare—should cover anti-obesity medications, ...

In countless reports and studies, obesity is often reduced to just a number: 42% of adults in the U.S. have obesity, ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with we ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

A proposed amendment, which is supported by the bill sponsors, would also require Nevada Medicaid to cover at least one ...